Increased Risk for Mental Health Disorders Seen With Head and Neck Cancers
Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.
Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.
Disparities between NCCN guideline-concordant treatment and actual care were most likely to occur in two patient populations.
Patients referred to the clinic were diagnosed nearly 2 weeks faster compared with historical controls.
In patients with complete response at transplant, age was found to be the only predictor of clinical outcomes.
Exercise tolerance was found to be associated with verbal fluency, dominant motor speed, and math academics, among other neurocognitive metrics.
A retrospective chart review conducted after implementing an ERAS program demonstrated that improved patient education led to less use of opioids in the immediate postoperative period.
Approximately one-third of patients in each treatment group experienced symptoms of depression and anxiety during treatment.
Of patients who experienced relapse within 6 months of frontline treatment, 17% achieved a complete response.
Researchers determined that several validated assessment tools are needed to measure health-related quality of life in patients with cutaneous T-cell lymphoma.
Using validated assessment tools, researchers compared patients’ perceptions of HRQOL while undergoing treatment for CML with 1 of 2 TKIs.